Remedial agent for anxiety neurosis or depression and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252180, C514S253010, C514S253060, C514S253120, C544S295000, C544S357000, C544S360000, C544S363000, C544S364000

Reexamination Certificate

active

06949552

ABSTRACT:
There are provided a therapeutic preparation for anxiety neurosis or depression which comprises a MC4receptor antagonist as an effective ingredient; and a piperazine derivative represented by Formula [1]:[wherein Ar1is a phenyl group, a substituted phenyl group, a naphthyl group or a substituted naphthyl group; Ar2is a naphthyl group, a substituted naphthyl group, a quinolyl group, a group represented by the formula:(wherein R4is a hydrogen atom or a halogen atom; and X—Y is CH—NH, CH—O, CH—S or N—O) or a group represented by the formula:(wherein R5is a hydrogen atom, a hydroxyl group or a C1-10alkoxy group); R1is a hydrogen atom, a C1-10alkyl group, a C3-8cycloalkyl group, a C3-10alkenyl group, a phenyl group, a 1-cyanoethyl group, a pyrimidin-2-yl group or an amidyl group; R2and R3are the same or different, and are each a hydrogen atom or a C1-10alkyl group; A-B is N—CH2, CH—CH2, C(OH)—CH2or C═CH; T1is a single bond, —N(R6)— (wherein R6is a hydrogen atom or a C1-10alkyl group), —O—, —CH═CH— or —C(═O)—; n is an integer of from 1 to 10 and when T1is a single bond, —CH═CH— or —C(═O)—, n is an integer of from 2 to 10 when T1is —N(R6)— or —O—], or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 5177078 (1993-01-01), Ward et al.
patent: 5532242 (1996-07-01), Cliffe
patent: 20 38 206 (1971-02-01), None
patent: 0 262 993 (1988-04-01), None
patent: 0479546 (1992-04-01), None
patent: 1317053 (1963-02-01), None
patent: 6-41071 (1994-02-01), None
patent: WO 93/14076 (1993-07-01), None
patent: WO 98/37097 (1998-08-01), None
patent: 99 64002 (1999-12-01), None
patent: PCT/JP01/05524 (2001-06-01), None
Vedjelek Z. et al., “Potential antitussives: synthesis and pharmacology of a series of 1-[2-amino-2(4-fluorophenyl)ethyl]-4-(2-benzoylpropyl) piperazines”, Collect. Czech. Chem. Commun., (1983), vol. 48, No. 10, pp. 2977 to 2988.
Kask A. et al., “Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo”, Endocrinology, (1998), vol. 139, No. 12, pp. 5006 to 5014.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Remedial agent for anxiety neurosis or depression and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remedial agent for anxiety neurosis or depression and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedial agent for anxiety neurosis or depression and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3385840

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.